United BioSource targets elearning for medical technology sector
Bethesda, Md., USA. United BioSource Corporation (UBC) has acquired
iLearn, an advanced learning management system developed by Warrington,
UK-based IQ Consultancy. The robust web-based technology allows UBC to offer
new enterprise learning services to pharmaceutical and biotechnology
clients. The acquisition is part of the UBC strategy of building integrated
capabilities to meet growing demand by the pharmaceutical, biotechnology,
medical device and diagnostics sectors for evidence-based product
development and commercialization services.
The iLearn technology, to be renamed the "UBC Learning Zone", operates
from a secure, validated web-based platform and will enable UBC to deliver
effective, user friendly, training programs that can be accessed at any time
from any location with an Internet connection. It can deliver didactic
training presentations, instructor-led sessions, and supporting materials
and documentation. UBC clients can use the UBC Learning Zone for a broad
array of training and education needs, including investigator training,
medical education for health care professionals, and a broad array of
patient-based education, including disease management, drug compliance and
patient retention programs. International training and education projects
have been successfully implemented at several leading pharmaceutical
companies.
"The UBC Learning Zone is an important addition to UBC's rapidly-growing
portfolio of technologies," said Catherine Spear, Group President of UBC's
Training and Education Group. "This robust, secure and reliable system will
help us build and deploy customized training programs that meet our clients'
global needs. Because this technology was designed specifically for heavily
regulated industries, it offers all of the essential compliance, reporting
and regulatory tools necessary in the pharmaceutical, biotechnology and
medical device industries."
The acquisition is the latest in a series of strategic moves announced
since UBC raised $153 million in equity capital from a syndicate of leading
private equity firms. Other recent acquisitions include MetaWorks Inc, a
leading provider of systematic reviews and meta-analyses to inform
development, marketing, and regulatory decision-making regarding health care
products and services.
To top
|
|